Nanowear

Nanowear has produced the first FDA 510(k) cleared cloth-based nanotechnology monitoring platform, bringing health monitoring into high definition with unmatched patient experience.

Millions of individuals suffer from chronic diseases that require continuous monitoring, many of whom are Medicaid, Medicare or uninsured patients. This population is the single largest driver of healthcare costs worldwide.Heart Failure, the chronic disease management case of our time, affects 7 million Americans costing the US healthcare system $40 billion annually due to all-too-frequent Heart Failure related hospitalizations. One-third of these patients are Medicaid or uninsured.Beginning with Heart Failure and related co-morbidities, Nanowear delivers high-fidelity alert diagnostics and bridges the gap between cost reduction and patient care. Nanowear's goal is to protect patient lives and enable the flexibility to live freely.

Our mission is to improve the quality of preventive medicine, practitioner productivity, patient care and physical performance through nanotechnology- and machine learning-enabled diagnostic monitoring.